Back to top

TERMINATION AGREEMENT

Termination Agreement

TERMINATION AGREEMENT | Document Parties: GENEREX BIOTECHNOLOGY CORP | ELAN CORPORATION, PLC | ELAN INTERNATIONAL SERVICES, LTD | GENEREX (BERMUDA), LTD You are currently viewing:
This Termination Agreement involves

GENEREX BIOTECHNOLOGY CORP | ELAN CORPORATION, PLC | ELAN INTERNATIONAL SERVICES, LTD | GENEREX (BERMUDA), LTD

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: TERMINATION AGREEMENT
Governing Law: New York     Date: 6/14/2005
Industry: Biotechnology and Drugs     Sector: Healthcare

TERMINATION AGREEMENT, Parties: generex biotechnology corp , elan corporation  plc , elan international services  ltd , generex (bermuda)  ltd
50 of the Top 250 law firms use our Products every day

 

Exhibit 4.19

 

DATED 17 DECEMBER 2004

 

 

 

(1) ELAN CORPORATION, PLC

 

 

(2) ELAN INTERNATIONAL SERVICES, LTD

 

 

(3) GENEREX BIOTECHNOLOGY CORPORATION

 

 

AND

 

 

(4) GENEREX (BERMUDA), LTD

 

 

 

 


 

 

TERMINATION AGREEMENT

 

 


 

 

 

 

 

 

 

 

 

 

 

MATHESON ORMSBY PRENTICE

30 Herbert Street

Dublin 2

Ireland

 

TEL + 353 1 619 9000

FAX + 353 1 619 9010

\MOP_DUBLIN\1081878.5

 

 

 


CONTENTS

 

 

 

 

 

 

Page No

 

 

 

1

Definitions

2

2

Termination of the Newco Agreements

3

3

Representations, Warranties, Confirmations and Indemnities

4

4

Intellectual Property

6

5

Rights Related to Securities

6

6

Sale of Shares and Completion

6

7

Confidentiality

7

8

Waiver of Accrued Rights/Mutual Releases

9

9

General

9

 

 

 

 

 


 

 

THIS TERMINATION AGREEMENT made this 17 th day of December 2004 (this “ Agreement ”)

 

AMONG:

 

(1)  

ELAN CORPORATION, PLC , a public limited company incorporated under the laws of Ireland and having its registered office at Lincoln House, Lincoln Place, Dublin 2, Ireland (“ Elan Corp ”);

 

(2)  

ELAN INTERNATIONAL SERVICES, LTD., an exempted limited liability company incorporated under the laws of Bermuda, and having its registered office at Clarendon House, 2 Church St., Hamilton, Bermuda ( “EIS” );

 

(3)  

GENEREX BIOTECHNOLOGY CORPORATION , a Delaware corporation having its principal place of business at 33 Harbour Square, Suite 202, Toronto, Ontario, Canada M5J 2G2; and

 

(4)  

GENEREX (BERMUDA), LTD ,   an exempted company incorporated under the laws of Bermuda, and having its registered office at Clarendon House, 2 Church St., Hamilton, Bermuda.

 

RECITALS:

 

A.  

The Parties entered into various agreements whereby Elan Corp, EIS and JVP established the joint venture company, Newco, and Elan Corp and JVP each licensed certain intellectual property to Newco for a specified field of use. Specifically:

 

(i)  

Elan Corp, EIS, JVP and Newco entered into a Subscription, Joint Development and Operating Agreement dated 17 January 2001 as amended and restated on 15 January 2002 (the “ JDOA ”);

 

(ii)  

Elan Corp and Newco entered into a License Agreement dated 16 January 2001 as amended and restated on 15 January 2002 (the “ Elan License Agreement ”);

 

(iii)  

JVP and Newco entered into a License Agreement dated 16 January 2001 as amended and restated on 15 January 2002 (the “ JVP License Agreement ”); and

 

(iv)  

Newco, JVP and EIS entered into a Registration Rights Agreement with respect to the capital stock of Newco dated 16 January 2001 (the “ Newco Registration Rights Agreement ”).

 

B.  

The JDOA, Elan License Agreement, JVP License Agreement, and Newco Registration Rights Agreement, are together defined in this Agreement as the “ Newco Agreements ”.

 

C.  

The Parties also entered into agreements whereby JVP sold and EIS purchased certain securities of JVP and the Parties agreed to certain matters related to the ownership of such securities. Specifically:

 

(i)  

Elan Corp, EIS and JVP entered into a Securities Purchase Agreement dated 16 January 2001 (the “ Securities Purchase Agreement ”);

 

(ii)  

EIS and JVP entered into a Registration Rights Agreement with respect to the capital stock of JVP dated 16 January 2001 (the “ JVP Registration Rights Agreement ”); and

 

(iii)  

JVP executed and delivered to EIS a Warrant to Purchase Shares dated 16 January 2001 (the “ Warrant ”).

 

D.  

The Securities Purchase Agreement and JVP Registration Rights Agreement are together defined in this Agreement as the “ Security Agreements ”.

 

 

1


 

E.  

The Parties wish to (i) terminate in full the Newco Agreements as set forth below, (ii) set forth their agreement in relation to other matters including, inter alia, the transfer of shares by EIS to JVP, and (iii) terminate in full the Security Agreements and amend the Warrant as set forth below.

 

IN CONSIDERATION OF THE MUTUAL COVENANTS CONTAINED HEREIN, AND OTHER GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND ADEQUACY OF WHICH ARE HEREBY ACKNOWLEDGED, IT IS HEREBY AGREED AS FOLLOWS:

 

 

DEFINITIONS

 

Capitalised terms used in this Agreement shall have the same meanings assigned to them in the Newco Agreements, unless such terms are expressly defined to the contrary in this Agreement.

 

Affiliate” shall mean any corporation or entity controlling, controlled or under the common control of any other corporation or entity, excluding, in the case of Elan Corp, an Elan JV. For the purpose of this definition, (i) “control” shall mean direct or indirect ownership of fifty percent (50%) or more of the stock or shares entitled to vote for the election of directors; and (ii) Newco shall not be an Affiliate of Elan Corp or EIS.

 

Effective Date ” shall mean the date of this Agreement.

 

“Elan” shall mean Elan Corp and its Affiliates.

 

Elan Improvements ” shall mean improvements to the Elan Patents and/or the Elan Know-How, developed (i) by Elan outside the Project, (ii) by Elan, JVP or Newco or by a third party (under contract with Newco, Elan or JVP) pursuant to the Project, and/or (iii) jointly by any combination of Elan, JVP, Newco or a third party (under contract with Newco, Elan or JVP) pursuant to the Project.

 

“Elan JV” shall mean an entity that Elan and a third party (i) establish or have established; (ii) take shareholdings in or have a right to take shareholdings in; and (iii) grant certain licenses in and to certain intellectual property rights for the purpose of implementing a strategic alliance.

 

“Elan Know-How” shall have the meaning set forth in the Elan Licence Agreement.

 

“Elan Patents” shall have the meaning set forth in the Elan Licence Agreement.

 

“Elan Trademark(s)” shall have the meaning set forth in the Elan Licence Agreement.

 

“Exchange Right” has the meaning assigned to such term in the Certificate of Designations.

 

Force Majeure ” shall mean causes beyond a Party’s reasonable control, including, without limitation, acts of God, fires, strikes, acts of war, or intervention of a governmental authority.

 

JVP ” shall mean Generex Biotechnology Corporation and its Affiliates.

 

JVP Improvements ” shall mean improvements to the JVP Patents and/or the JVP Know-How, developed (i) by JVP outside the Project, (ii) by JVP, Elan or Newco or by a third party (under contract with Newco, Elan or JVP) pursuant to the Project, and/or (iii) jointly by any combination of JVP, Elan, Newco or a third party (under contract with Newco, Elan or JVP) pursuant to the Project.

 

JVP Know-How ” shall mean Generex Know-How (as such term is defined in the JVP Licence Agreement).

 

JVP Patents ” shall mean Generex Patents (as such term is defined in the JVP Licence Agreement).

 

 

2


 

JVP Trademarks ” shall mean Generex Trademarks (as such term is defined in the JVP Licence Agreement).

 

Newco ” shall mean Generex (Bermuda), Ltd. and its Affiliates.

 

Newco Intellectual Property ” shall have the meaning set forth in the JDOA.

 

“Newco Trademark” shall mean Generex (Bermuda), Ltd..

 

Party ” shall mean Elan Corp, EIS, JVP or Newco, as the case may be, and “ Parties ” shall mean all such parties together.

 

“Project” shall have the meaning set forth in the JDOA.

 

“Territory” shall mean all of the countries of the world.

 

“United States Dollar” and “US$” and “$” shall mean the lawful currency of the United States of America.

 

2  

TERMINATION OF THE NEWCO AGREEMENTS

 

2.1  

Subject to the provisions of Clause 2.2 hereof, the Parties hereby agree to terminate the Newco Agreements and the Security Agreements, including without limitation, those provisions expressly stated to survive termination, in each case with effect from the Effective Date.

 

All the provisions of the Newco Agreements and the Security Agreements shall terminate forthwith with effect from the Effective Date and be of no further legal force or effect.

 

2.2  

For the avoidance of doubt and without prejudice to the generality of the foregoing Clause 2.1, the Parties hereby acknowledge and agree as follows as of the Effective Date:

 

2.2.1  

the Management Committee (as such term is defined in the JDOA) shall be dissolved forthwith with effect from the Effective Date and thereby cease to have any function;

 

2.2.2  

the EIS Director, Seamus Mulligan, holding office with Newco immediately prior to the Effective Date, shall resign;

 

2.2.3  

the nominees on the Management Committee of Elan shall be deemed to have been removed from the Management Committee by Elan immediately prior to the dissolution of the Management Committee;

 

2.2.4  

all rights granted to Newco pursuant to the Elan License Agreement to use the Elan Patents, the Elan Know-How, the Elan Improvements and the Elan Trademark(s) shall terminate forthwith;

 

2.2.5  

all rights granted to Newco pursuant to the JVP License Agreement to use the JVP Patents, the JVP Know-How, the JVP Improvements and the JVP Trademark(s) shall terminate forthwith;

 

2.2.6  

with effect from the Effective Date, neither JVP nor Newco shall have any rights in or to the Elan Patents, the Elan Know-How, the Elan Improvements and/or the Elan Trademark(s) and/or any other patents, know-how or any other intellectual property rights whatsoever of Elan;

 

2.2.7  

with effect from the Effective Date, neither Elan nor Newco shall not have any rights in or to the JVP Patents, the JVP Know-How, the JVP Improvements and/or the JVP Trademarks and/or any other patents, know-how or any other intellectual property rights whatsoever of JVP;

 

 

3


 

2.2.8  

the Parties shall terminate or shall cause to be terminated any and all research and development work being conducted in connection with or pursuant to any R&D Program of Newco, the Newco Agreements, or otherwise on behalf of Newco;

 

2.2.9  

the Parties shall terminate or cause to be terminated any and all technical services and assistance being conducted in connection with the Newco Agreements;

 

2.2.10  

for the avoidance of doubt, none of the Parties shall have any obligation to provide working capital, research or development funding, or other funding or financing of any nature to Newco;

 

2.2.11  

Elan shall not have any obligation to pay any milestone payment or make any milestone investment to or in Newco or JVP whether relating to the Project, the achievement of any objectives set forth therein or otherwise.

 

2.3  

Each of the Parties acknowledges and agrees with the other Parties that, as of the Effective Date, no monies are owed or are refundable by any of the Parties to the others pursuant to the Newco Agreements.

 

For the avoidance of doubt, the Parties acknowledge that Newco is liable to pay any fees due and owing to Codan Corporate Administrative Services upon the Effective Date, and thereafter.

 

3  

REPRESENTATIONS, WARRANTIES, CONFIRMATIONS AND INDEMNITIES

 

3.1  

Sub-licenses

 

Newco represents and warrants to the other Parties that it has not granted any sub-licences or any other rights of any nature to any third parties pursuant to the Elan License Agreement or the JVP License Agreement.

 

3.2  

JVP Shares

 

JVP confirms to the other Parties that it is the legal and beneficial owner of (i) 6000 Common Shares (as defined in the JDOA and (ii) 3,612 Preference Shares (as defined in the JDOA).

 

3.3  

EIS Shares

 

EIS confirms to the other Parties that it is the legal and beneficial owner of 2,388 Preference Shares (the “ EIS Shares ”).

 

3.4  

Third party agreements / Orders / Claims

 

3.4.1  

Each of the Parties confirms to the other Parties hereto that, as of the Effective Date, to its actual knowledge, Newco is not a party to, or bound by, any judgment, order, decree or other directive of or stipulation with any court or any governmental or regulatory authority.

 

3.4.2  

Each of the Parties confirms to the other Parties hereto that, as of the Effective Date, to its actual knowledge, Newco is not a party to, or bound by, or is a third party beneficiary of any agreement with any third party except for the Newco Agreements.

 

3.4.3  

Each of the Parties confirms to the other Parties hereto that, as of the Effective Date, to its actual knowledge, there are no claims, suits or proceedings pending or threatened against Newco.

 

3.5  

Regulatory Applications

 

Each of the Parties confirms to the other Parties that, prior to and as of the Effective Date, no regulatory applications have been filed by Newco or by any Party with any government authority in any part of the world with respect to the Newco Intellectual Property or otherwise howsoever in relation to the Project.

 

 

4


 

3.6  

Exclusion of warranties / liability

 

WITH REFERENCE TO THE TRANSFER BY EIS TO JVP OF THE EIS SHARES AS PROVIDED BY CLAUSE 6 ON THE EFFECTIVE DATE (BUT WITHOUT PREJUDICE TO EIS’S OBLIGATION UNDER CLAUSE 6.1.1 HEREOF TO TRANSFER THE EIS SHARES TO JVP FREE FROM ALL LIENS, CHARGES AND ENCUMBRANCES), THE PARTIES ACKNOWLEDGE AND AGREE THAT EIS AND ITS AFFILIATES MAKE NO REPRESENTATION OR WARRANTY OF ANY NATURE TO JVP OR ANY OTHER PERSON IN RELATION TO NEWCO OR ANY OF ITS AFFAIRS PAST, PRESENT OR FUTURE.

 

JVP ACKNOWLEDGES THAT IT IS ENTERING INTO THIS AGREEMENT IN RELIANCE EXCLUSIVELY ON ITS OWN BUSINESS JUDGEMENT, THE INFORMATION WHICH HAS BEEN AVAILABLE TO IT AS A SHAREHOLDER OF NEWCO AND OTHERWISE AND ON THE DUE DILIGENCE IT HAS CARRIED OUT IN RELATION TO NEWCO.

 

EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, ALL OTHER WARRANTIES, CONDITIONS OR REPRESENTATIONS, EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, ARE HEREBY EXPRESSLY EXCLUDED BY THE PARTIES.

 

NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, NO PARTY SHALL BE LIABLE TO ANY OTHER PARTY BY REASON OF ANY REPRESENTATION OR WARRANTY,


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more